Clariant shareholders approve Süd-Chemie deal
31/03/2011
Clariant announced its intention to make this move in February. At the end of March, the company's 16th annual general meeting adopted this, and each of the resolutions proposed by the board of directors.
In total, 515 shareholders, representing roughly 31% of the share capital recorded in Clariant's share register, attended the meeting on March 31 in Basel.
The Board of Directors was authorised by the AGM to create share capital for the acquisition of Munich-based Süd-Chemie. Current Süd-Chemie board members Dr Dolf Stockhausen and Konstantin Winterstein, as well as Süd-Chemie chief executive, Dr Günter von Au, were elected to the Clariant board of directors.
Share this story:
